Department of Pediatrics

Pittsburgh Lends Expertise, Arms to Moderna Vaccine Development
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
A depiction of the coronavirus
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
A woman in glasses and a black top holds a ear-shaped device to her head
It’s only fair that the Pitt Innovation Challenge would itself need to innovate. Find out which projects won this year’s competition—which awarded nearly $500,000—and how participants adjusted to a virtual event.
vials and a syringe
Hundreds of people in Western Pennsylvania will have the opportunity to participate in clinical research trials for vaccines against the coronavirus that causes COVID-19, UPMC and the University of Pittsburgh announced today.
A person in a yellow t-shirt and face mask walks on campus
Expert faculty members in the University of Pittsburgh’s School of Medicine are at the helm of a new COVID-19 Medical Response Office, which will oversee the implementation of a virus monitoring program on all five Pitt campuses. The program will direct the University’s COVID-19 testing, contact tracing, reporting procedures and isolation and quarantine protocols.
Anantha Shekhar in a dark blue suit
The advisory group is part of the University’s resilience framework, a process and structure for continuing Pitt’s operations and activities during the COVID-19 pandemic.